Skip to main content

Table 2 Clinical data of the 199 end-stage liver disease (Child-Pugh class A, child B, and child C)

From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation

  End-stage liver disease patients
Child A Child B Child C P value
N=79 N=43 N=77  
Age 60 a
(55–64)
55b
(51–60)
52c
(48.50–57)
<0.001 HS
Hb.% 12.5 a
(11–13.70)
12 b
(10.70–13)
12b
(11–13)
0.031
WBCsX103 5.30 a
(4.30–6.50)
5.10 a
(4–6)
5.60 a
(4–6.95)
0.6
PlateletsX103 130 b
(96–160)
156 ab
(90–180)
165 a
(121–210)
<0.001 HS
ALT 43 a
(34–50)
40 a
(33–47)
46 a
(30–110)
0.09
AST 52 a
(45–63)
48 a
(29–65)
46 a
(21.5–86.5)
0.509
Alb. 3.50 b
(3.20–3.80)
3.40 b
(2.80–3.80)
3.80 a
(3.45–4.00)
<0.001 HS
Creat. 1.00 a
(0.90–1.10)
1.00 a
(0.90–1.10)
1.00 a
(0.90–1.10)
0.86
  1. Data are expressed as median (IQR). Hb. states to hemoglobin, ALT states to serum alanine aminotransferase, and AST states to serum aspartate aminotransferase, Alb. states to albumin
  2. Identical letters in rows mean no significant difference at the level of 0.05
  3. Different letters in rows mean significant difference at the level of 0.05
  4. HS means highly significant